ACHL

Achilles Therapeutics plc American Depositary Shares
ACHL

Overview Fund Activity
Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

22 hedge funds and large institutions have $24.8M invested in Achilles Therapeutics plc American Depositary Shares in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
3
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
BML Capital Management
Indiana
$4.18M
2
CCM
Corsair Capital Management
New York
$20.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$12.7K
4
Morgan Stanley
Morgan Stanley
New York
$16.8K
5
AIM
Arcadia Investment Management
Michigan
$3.06K

Top Sellers

1
BBA
Baker Bros. Advisors
New York
$0
2
AG
Artal Group
Luxembourg
$0
3
UBS Group
UBS Group
Switzerland
$0
4
Citadel Advisors
Citadel Advisors
Florida
$0
5
Renaissance Technologies
Renaissance Technologies
New York
$651K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$50K -61,391 Closed
XT
27
XTX Topco
Cayman Islands
– -$42.1K -51,660 Closed
VF
28
Virtu Financial
New York
– -$19K -22,813 Closed
HF
29
HRT Financial
New York
– -$8K -10,942 Closed
GRP
30
Global Retirement Partners
California
– -$1.63K -2,000 Closed
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
– -$59 -73 Closed
1
2